Compile Data Set for Download or QSAR
Report error Found 51 of affinity data for UniProtKB/TrEMBL: Q15040
TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699772(US20240335427, Compound 3)
Affinity DataIC50: 28nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699773(US20240335427, Compound 4)
Affinity DataIC50: 45nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699774(US20240335427, Compound 5)
Affinity DataIC50: 74nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699775(US20240335427, Compound 6)
Affinity DataIC50: 82nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699776(US20240335427, Compound 7)
Affinity DataIC50: 95nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699777(US20240335427, Compound 8)
Affinity DataIC50: 99nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699778(US20240335427, Compound 9)
Affinity DataIC50: 150nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699779(US20240335427, Compound 2)
Affinity DataIC50: 160nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699780(US20240335427, Compound 10)
Affinity DataIC50: 160nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699781(US20240335427, Compound 11)
Affinity DataIC50: 160nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699782(US20240335427, Compound 12)
Affinity DataIC50: 244nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699783(US20240335427, Compound 13)
Affinity DataIC50: 260nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699784(US20240335427, Compound 14)
Affinity DataIC50: 270nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699785(US20240335427, Compound 15)
Affinity DataIC50: 288nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699786(US20240335427, Compound 16)
Affinity DataIC50: 305nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699787(US20240335427, Compound 17)
Affinity DataIC50: 370nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699788(US20240335427, Compound 18)
Affinity DataIC50: 380nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699789(US20240335427, Compound 19)
Affinity DataIC50: 420nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699790(US20240335427, Compound 20)
Affinity DataIC50: 430nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699791(US20240335427, Compound 21)
Affinity DataIC50: 460nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699792(US20240335427, Compound 22)
Affinity DataIC50: 520nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM50590283(CHEMBL5169766 | US20230303547, Reference Example D...)
Affinity DataIC50: 660nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699794(US20240335427, Compound 24)
Affinity DataIC50: 690nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699795(US20240335427, Compound 25)
Affinity DataIC50: 931nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699796(US20240335427, Compound 26)
Affinity DataIC50: 1.10E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699797(US20240335427, Compound 27)
Affinity DataIC50: 1.10E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699798(US20240335427, Compound 28)
Affinity DataIC50: 1.22E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699799(US20240335427, Compound 29)
Affinity DataIC50: 1.24E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699800(US20240335427, Compound 30)
Affinity DataIC50: 1.37E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699801(US20240335427, Compound 31)
Affinity DataIC50: 1.40E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699802(US20240335427, Compound 32)
Affinity DataIC50: 1.48E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699803(US20240335427, Compound 33)
Affinity DataIC50: 1.95E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM445205(US10669234, Example 144 | (S)-1-cyano-N-(4-(6-cyan...)
Affinity DataIC50: 2.13E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699805(US20240335427, Compound 35)
Affinity DataIC50: 2.77E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699806(US20240335427, Compound 36)
Affinity DataIC50: 3.37E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699807(US20240335427, Compound 37)
Affinity DataIC50: 3.96E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699808(US20240335427, Compound 38)
Affinity DataIC50: 4.15E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699809(US20240335427, Compound 39)
Affinity DataIC50: 4.85E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699810(US20240335427, Compound 40)
Affinity DataIC50: 5.68E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699811(US20240335427, Compound 41)
Affinity DataIC50: 6.07E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699812(US20240335427, Compound 42)
Affinity DataIC50: 6.23E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699813(US20240335427, Compound 43)
Affinity DataIC50: 6.42E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699814(US20240335427, Compound 44)
Affinity DataIC50: 8.25E+3nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM50538571(CHEMBL4635160)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human His6-tagged JOSD1 expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699815(US20240335427, Compound 45)
Affinity DataIC50: 1.12E+4nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699816(US20240335427, Compound 46)
Affinity DataIC50: 1.13E+4nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699817(US20240335427, Compound 47)
Affinity DataIC50: 1.32E+4nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699818(US20240335427, Compound 48)
Affinity DataIC50: 1.64E+4nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699819(US20240335427, Compound 49)
Affinity DataIC50: 2.03E+4nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetJosephin-1(Human)
DANA-FARBER CANCER INSTITUTE, INC.

US Patent
LigandPNGBDBM699820(US20240335427, Compound 50)
Affinity DataIC50: 2.13E+4nMAssay Description:In vitro JOSD1 activity assay was carried out with Ubiquitin-AMC assay. The Ubiquitin-AMC assay was carried out as previously described (Wernig, et a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: